Legal Issues

Aurion Biotech plans to IPO on the New York Stock Exchange under the ticker "AURN." Challenges include a lawsuit from Alcon Research alleging violations of shareholder rights. Aurion countersued, accusing…

**Biotech firm Athira Pharma, located in the Seattle area, has reached a significant settlement of $4.07 million.** This resolution comes after allegations surfaced regarding violations of the False Claims Act,…